Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms. LMJHCR 2025, 3 (2), e76. https://doi.org/10.61919/gsj6hy59.